Smiths Detection and Riskaware join forces to develop next generation CBRN solution
24.9.2024 09:00:00 CEST | Business Wire | Press release
‘UrbanAware’ collects and analyses data to deliver critical incident intelligence straight to the tactical edge
Smiths Detection, a global leader in threat detection and security screening technologies, and a business of Smiths Group, in partnership with Riskaware, an incident modelling specialist, have today launched UrbanAware, an end-to-end platform to augment, integrate and digitise the delivery of chemical, biological, radiological and nuclear (CBRN) hazard intelligence in real time during an incident.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240924728864/en/
(Graphic: Business Wire)
This joint solution not only closes the gap between data collection, analysis and strategic awareness of CBRN threats, it also brings insights closer to the tactical edge, enabling stakeholders to quickly identify and understand chemical and other hazards in the field. Threats can be seen in real time on a map in relation to the team’s position, thus providing critical and potentially life-saving intelligence. Likely next stages of a chemical attack or accidental industrial release can also be forecast using the simulation capabilities.
Dr Sarah Robinson, Global Industry Director - Defence at Smiths Detection, said: “Our partnership represents a joint mission to create safer spaces and address complex global challenges in order to protect people, environments, infrastructure and societies worldwide. First responders and military planners need to act quickly when faced with disaster management and UrbanAware enables incredibly fast access to critical information. When combined with sensor data, it becomes a very powerful tool as a situation unfolds – supporting faster, more informed response strategies.”
Landscape and population considerations make it challenging to evaluate the potential impact of any incident and determine the best course of action. As the name suggests, UrbanAware is optimised for these complex urban environments where the topography of streets and buildings influences dispersion of airborne hazards. Typical use cases range from planning evacuation routes in a civil emergency to establishing optimal cordon areas based on predictive hazard modelling.
Underpinning Riskaware’s CBRN system is the Hazard Assessment Simulation and Prediction (HASP) Suite, which was developed over two decades by the Defence Science and Technology Laboratory (Dstl) and is licensed to Riskaware by Ploughshare. The HASP Suite was originally developed to provide rapid hazard prediction in complex urban environments in a matter of minutes, greatly improving upon previous models. It also takes into consideration the interactions between indoor and outdoor dispersion and is able to estimate source parameters, such as location, discharge time, and the amount of substance released. Integrating these robust capabilities with Smith Detection’s well established chemical sensor gives defence and security organisations a rich hazard modelling solution which surpasses any traditional options.
Dr James Christley, Senior Principal Scientist, Dstl, said: “Sustained Defence investment in science and technology consistently produces innovation that protects lives. We’re pleased that Dstl’s work developed originally for UK Defence will be exploited to benefit a wider audience.”
Simon Agass, Riskaware Business Development Director, added: “We’ve worked with multiple military agencies and have seen that the available CBRN solutions are highly manual and not fit for purpose in today’s threat landscape. Bringing together our comprehensive CBRN modelling capabilities with Smith Detection sensor technology provides a much-needed, end-to-end CBRN incident response capability that saves critical time, informs targeted action and protects more people.”
About Riskaware
Riskaware is a leading incident modelling solutions provider. Using data, systems and software expertise, it creates operational solutions that support organisations to make informed decisions and enhance their resilience. Working primarily with defence and security industries, Riskaware helps its partners address the most complex global challenges and protect people and environments worldwide.
About Smiths Detection
Smiths Detection is a global leader in threat detection and security screening technologies. It delivers the solutions needed to protect society from the threat and illegal passage of explosives, prohibitive weapons, contraband, biological threats, toxic chemicals and narcotics, to protect people and infrastructure.
HASP Suite Background Information
The Hazard Assessment Simulation and Prediction (HASP) Suite is a software toolset providing superior situational awareness and decision support in the CBRN/HazMat domain. It has been developed by the Defence Science and Technology Laboratory (Dstl) in conjunction with Riskaware and licensed by Ploughshare Innovations. 1
The HASP Suite is comprised of a number of individual components, each tackling a different aspect of the CBRN/HazMat challenge to create complete situational awareness. These include:
- Urban Dispersion Model (UDM)
- Urban Subsystem (USS)
- Sensor Placement Tool (SPT)
- Source Term Estimation (STE)
- Geographical and Environmental Database Information System (GEDIS)
A core component of the HASP Suite is the Urban Dispersion Model (UDM). UDM was originally funded by Dstl and the US Defense Threat Reduction Agency (DTRA) to satisfy a requirement for a numerical model that accurately predicts the dispersion of airborne contaminants through urban areas at ranges between about 10 m and 10 km. The model needed to be fast running in order to meet 'real-time' incident support requirements and operational analysis requirements. Since its inception in the 1990's UDM has been used in support of many major events. Early examples, in the public domain, include2:
- 2000 Sydney Olympics
- 2001 US Presidential Inauguration
- 2002 Salt Lake City Winter Olympics
- 2004 Athens Olympics
Throughout its development, the UDM has been validated in a number of field trial experiments including 2:
- Project Prairie Grass
- Urban 2000 Dataset, Salt Lake City, Utah
- Joint Urban 2003, Oklahoma City release
- Madison Square Gardens 2005
- Wind tunnel experiments
- MUST Experiment, Conex containers to create mock urban setting
UDM has also undergone independent external reviews, including:
- Defence Scientific Advisory Council (2006)
- Scientific Review by Hanna Consultants (2009)
UDM and other components of the HASP Suits have also received significant funding from the US Department of Defense through the US Program of Record and are integrated into the US Hazard Prediction and Analysis Capability (HPAC) and the Joint Effects Model (JEM)3,4,5, 6. Riskaware continue to support these programmes though its US Prime Contractor partnerships.
| _________________________ |
1 “The UDM A Puff Model for Estimating Dispersion in UrbanAreas”, D.J. Hall, A.M. Spanton, I.H. Griffiths, M. Hargrave, S.Walker, C. John, 7th Int. Conf. on Harmonisation within Atmospheric Dispersion Modelling for Regulatory Purposes (https://www.yumpu.com/en/document/view/22174201/the-udm-a-model-for-estimating-dispersion-in-urban-areas) |
2 “Atmospheric Dispersion Modelling in Support of Civil Emergency Operations”, Ben Swindlehurst, Dstl, https://apps.dtic.mil/sti/tr/pdf/ADA460246.pdf |
3 “Acceptance of mathematical modelling - a defence science perspective”, Paul Westoby, CBR Advice Dstl. https://nc3rs.org.uk/sites/default/files/documents/Workshop_reports/maths/14%20-%20Defence%20%E2%80%93%20Dr%20Paul%20Westoby,%20DSTL.pdf |
4 “Acceptance criteria for urban dispersion model evaluation”, Steven Hanna, Joseph C. Chang, Meteorology and Atmospheric Physics 116(3-4), https://www.researchgate.net/publication/257448979_Acceptance_criteria_for_urban_dispersion_model_evaluation |
5 “The Geographical and Environmental Database Information System (GEDIS) as a Tool for Urban Dispersion Modelling”, Richard N. Fry, Jr. Defense Threat Reduction Agency, Ian Griffiths* Dstl, Iain Crawford, Tim Dudman, Matthew Gilbert and David Stewart RiskAware Ltd, https://ams.confex.com/ams/pdfpapers/80142.pdf |
6 “Urban Subsystem CBRN Dispersion Modeling”, CBRNE Central, Urban Subsystem CBRN Dispersion Modeling (cbrnecentral.com) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20240924728864/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom